Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2026-05-21 16:05:21 ET · period of report 2026-05-19 · accession 0001193125-26-234397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:05 | 2026-05-19 | IRWD | Silver Ronald | PFO, PAO | A - Grant | $0.00 | +25.0K | 441.6K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | A | A | 25,000 | $0.00 | 441,570 | D | — | — | (F1) The restricted stock unit award vests as to 50% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof. |